Clinical Study

Flow-Volume Parameters in COPD Related to Extended Measurements of Lung Volume, Diffusion, and Resistance

Figure 3

RV% (a) and TLC%p (b) measured by body plethysmography and single breath helium dilution with CO-diffusion. Difference in RV% ( ) (c) and TLC% ( ) (d) measured by body plethysmography and single breath helium dilution with CO-diffusion in controls (healthy smokers) and COPD patients with GOLD stage 1–4. *Significant difference compared to healthy smokers, significant difference compared to GOLD1, significant difference compared to GOLD2, #significant difference compared to GOLD3; §significant difference between measurement from body plethysmography compared to single breath helium dilution with CO-diffusion, one symbol flagging , two symbols flagging , and three symbols flagging . Data are presented as median (IQR) in (a)-(b) and individual dots together with median with interquartile range (c)-(d).
782052.fig.003a
(a)
782052.fig.003b
(b)
782052.fig.003c
(c)
782052.fig.003d
(d)